Molecular Carcinogenesis Journal Citation Rate 2026

ISSN 0899-1987 eISSN 1098-2744 Wiley US

Q2 Quartile Established Impact Verified Publisher

About Molecular Carcinogenesis
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Molecular Carcinogenesis (MC) is a peer-reviewed academic journal covering Cancer-related Molecular Pathways and Cancer-related molecular mechanisms research, published by Wiley in US, catalogued under ISSN 0899-1987 (e-ISSN 1098-2744). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 2.69 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4220 USD).

Molecular Carcinogenesis Citation Rate 2026 — In Context

Molecular Carcinogenesis has a 2025 2-Year Citation Rate (OpenAlex) of 2.69, placing it in the Q2 quartile within the Cancer-related Molecular Pathways research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Molecular Carcinogenesis operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Molecular Carcinogenesis should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Molecular Carcinogenesis against similar journals in the field, use our journal comparison tool.

Submission Tips for Molecular Carcinogenesis
  • Budget $4220 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Cancer-related Molecular Pathways, Cancer-related molecular mechanisms research, DNA Repair Mechanisms. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Molecular Carcinogenesis Compares
Citation Rate vs Field Avg
-5%
Field avg: 2.84
APC vs Field Avg
+44%
Field avg: $2921

Compared against 28 journals in the same research areas.

ISSN (Print) 0899-1987
ISSN (Online) 1098-2744
Publisher Wiley
Country United States
APC / Cost $4220 USD
In-depth profile & metrics

Molecular Carcinogenesis is published by Wiley and based in United States. It runs on a subscription or hybrid model with an article-processing charge of USD 4220.

In our subject taxonomy, Molecular Carcinogenesis is classified under Cancer-related Molecular Pathways, Cancer-related molecular mechanisms research, DNA Repair Mechanisms and Epigenetics and DNA Methylation.

Molecular Carcinogenesis is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 2.691.

Research Areas
Links
Frequently Asked Questions about Molecular Carcinogenesis

Molecular Carcinogenesis does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 2.691 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Molecular Carcinogenesis is not an open access journal.

The Article Processing Charge (APC) for Molecular Carcinogenesis is $4220 USD.

Molecular Carcinogenesis is published by Wiley.

Molecular Carcinogenesis shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Molecular Carcinogenesis is 0899-1987. Its electronic ISSN (eISSN) is 1098-2744.

Molecular Carcinogenesis sits in the Q2 quartile based on its latest impact factor of 2.69, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
2.691
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 2.691 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Compare Journals

Compare Molecular Carcinogenesis against similar publications in its field:

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S133439003

Get weekly updates for Cancer-related Molecular Pathways journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google